New study explores safer IV access for chronic pain patients

NCT ID NCT07555314

Recruiting now Knowledge-focused Sponsor: Medical University of Warsaw Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether a type of IV line called a midline catheter can be used safely and effectively for repeated lidocaine infusions in an outpatient clinic. About 500 adults with chronic pain will receive ten lidocaine infusions through a midline catheter. Researchers will track how often the catheter works without needing a new IV, how long it lasts, and any problems that come up.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: midline catheter
What this could lead to: If successful, this could show that midline catheters are a practical option for repeated lidocaine infusions in outpatient settings, improving patient comfort and reducing hospital visits.
What could go wrong: This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may not apply to all patients, and there is a risk of catheter-related complications like infection or blockage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC PAIN LIDOCAINE INFUSION MIDLINE CATHETER OUTPATIENT

Contacts and locations

Locations

Szpital Kliniczny Dzieciątka Jezus
RECRUITING

Warsaw, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.